Regen BioPharma, Inc.
RGBP
$0.01
$0.0020.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -90.75% | -34.64% | -35.28% | -66.43% | -157.78% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 279.31% | -274.10% | -230.21% | -492.45% | -3,322.22% |
| Total Other Non-Cash Items | 301.60% | 168.21% | -17.88% | -17.88% | -66.49% |
| Change in Net Operating Assets | 113.84% | 0.18% | 490.60% | 360.79% | 86.81% |
| Cash from Operations | 48.96% | 24.08% | -13.59% | -101.29% | -332.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 344.26% | 110.15% | 71.21% | -41.22% | -68.21% |
| Total Debt Repaid | -- | 180.20% | 186.01% | 178.49% | -- |
| Issuance of Common Stock | -89.68% | -94.73% | -59.15% | 65.52% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -28.31% | -41.01% | -0.28% | 29.69% | 158.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.19% | -198.36% | -695.83% | -248.45% | -272.35% |